Recent studies have also demonstrated altered cytokine activity in schizophrenia,31–34 and enhancement of IFIT2 and IFIT3 by RP5-998N21.4 and the subsequent promotion of the immune defense response might partially counteract the defects caused by the disease, with protective or restorative effects against neurotoxicity. Here, IFIT2 is linked to schizophrenia.